In vitro transformation models: Modeling human cancer

Cell Cycle

Volumn 5, Issue 6, 2006, Pages 630-634

  Heeg, Steffen ^a   Doebele, Michaela ^a   Von Werder, Alexander ^a   Opitz, Oliver G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ALT; c myc; Cancer models; Immortilization; Malignant transformation; Mitogenic signals; p53; pRB; Telomerase

Indexed keywords

ONCOPROTEIN; TELOMERASE;

BREAST CANCER; CANCER; CANCER CELL; CARCINOGENESIS; CELL IMMORTALIZATION; CELL SURVIVAL; CELL TRANSFORMATION; ENZYME ACTIVITY; GENE ISOLATION; GLIOMA; HUMAN; IN VITRO STUDY; KARYOTYPE; LUNG CANCER; MALIGNANT TRANSFORMATION; MITOGENICITY; MUTATION; NONHUMAN; OVARY CANCER; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TELOMERE; TUMOR CELL;

EID: 33645303498     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-7.
2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000; 406:747-52.
3. Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell 2002; 1:299-305.
4. Yeang CH, Ramaswamy S, Tamayo P, Mukherjee S, Rifkin RM, Angelo M, Reich M, Lander E, Mesirov J, Golub T. Molecular classification of multiple tumor types. Bioinformatics 2001; 17:S316-22.
5. Hunter T. Oncoprotein networks. Cell 1997; 88:333-46.
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
7. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304:596-602.
8. Bishop JM. Viral oncogenes. Cell 1985; 42:23-38.
9. Ruley HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 1983; 304:602-6.
10. Stevenson M, Volsky DJ. Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol Cell Biol 1986; 6:3410-7.
11. Sager R, Tanaka K, Lau CC, Ebina Y, Anisowicz A. Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc Natl Acad Sci USA 1983; 80:7601-5.
12. O'Brien W, Stenman G, Sager R. Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci USA 1986; 83:8659-63.
13. Akagi T, Hanafusa H. Human diploid fibroblasts are refractory to oncogene-mediated transformation. Cell Cycle 2004; 3:257-58.
14. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954; 8:1-12.
15. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 2004; 91:1983-9.
16. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993; 7:139-46.
17. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-32.
18. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
19. Fuchs S, Ougolkov A, Spiegelman V, Minamoto T. Oncogenic β-catenin signaling networks in colorectal cancer. Cell Cycle 2005; 11:1522-39.
20. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991; 93:59-62.
21. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:614-36.
22. Bischoff FZ, Strong LC, Yim SO, Pratt DR, Siciliano MJ, Giovanella BC, Tainsky MA. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome. Oncogene 1991; 6:183-6.
23. Hurlin PJ, Maher VM, McCormick JJ. Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene. Proc Natl Acad Sci USA 1989; 86:187-91.
24. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-73.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
26. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994; 59:307-15.
27. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al. The RNA component of human telomerase. Science 1995; 269:1236-41.
28. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277:955-9.
29. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997; 90:785-95.
30. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumor cells with defined genetic elements. Nature 1999; 400:464-8.
31. Harada H. Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, von Werder A, Enders GH, Opitz OG, Rustgi AK. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003; 1:729-38.
32. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000; 21:477-84.
33. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: The essential role of counting. Curr Opin Genet Dev 2001; 11:98-103.
34. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. Embo J 1992; 11:1921-9.
35. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91:2900-4.
36. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52.
37. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8:279-82.
38. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002; 2:331-41.
39. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002; 347:1593-603, Review.
40. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196:33-9.
41. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L, Reddel RR. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995; 15:4745-53.
42. Shay JW, Wright WE. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 1989; 184:109-18.
43. Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, Wynford-Thomas D, Wyllie FS. Control of replicative life span in human cells: Barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol Cell Biol 1999; 19:3103-14.
44. Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan, WM, Topalian SL. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997; 57:995-1002.
45. Opitz OG, Suliman Y, Hahn WC, Harada H, Blum HE, Rustgi AK. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 2001; 108:725-32.
46. Shay JW, Van Der Haegen BA, Ying Y, Wright WE. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 1993; 209:45-52.
47. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396:84-8.
48. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. Genes involved in senescence and immortalization. Curr Opin Cell Biol 2000; 12:705-9.
49. Hahn WC. Senescence, telomere shortening and telomere maintenance. Cancer Biol Ther 2002; 1(4):398-40048.
50. Yu J, Boyapati A, Rundell K. Critical role for SV40 small-t antigen in human cell transformation. Virology 2001; 290:192-8.
51. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22:2111-23.
52. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 2001; 61:8838-44.
53. Rich JN, Guo C, McLendon RE, Bigner DD, Wang XF, Counter CM. A genetically tractable model of human glioma formation. Cancer Res 2001; 61:3556-60.
54. Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, Brooks MW, Fleming MD, Olsen JC, Miller SW, Weinberg RA, Hahn WC. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 2002; 21:4577-86.
55. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast Jr RC. A genetically defined model for human ovarian cancer. Cancer Res 2002; 64:1655-63.
56. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001; 15:50-65.
57. McCormick F. Signalling networks that cause cancer. Trends Cell Biol 1999; 9:M53-6.
58. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: 'It ain't over 'til it's over'. Trends Cell Biol 2000; 10:147-54.
59. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411:355-65.
60. Ellis CA, Clark G. The importance of being K-Ras. Cell Signal 2000; 12:425-34.
61. Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 1999; 112:S53-67.
62. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993; 53:3579-84.
63. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54.
64. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W, Peters G. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. Embo J 2002; 21:2936-45.
65. Seger YR, Garcia-Cao M, Piccinin S, Cunsolo CL, Doglioni C, Blasco MA, Hannon GJ, Maestro R. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2002; 2:401-13.
66. Lazarov M, Kubo Y, Cai T, Dajee M, Tarutani M, Lin Q, Fang M, Tao S, Green CL, Khavari PA. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat Med 2002; 8:1105-14.
67. Drayton S, Rowe J, Jones R, Vatcheva R, Cuthbert-Heavens D, Marshall J, Fried M, Peters G. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 2003; 4:301-10.
68. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: The essential role of counting. Curr Opin Genet Dev 2001; 11:98-103.
69. Boehm JS, Hession MT, Bulmer SE, Hahn WC. Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol 2005; 25:6464-74.
70. Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, Doebele M, von Werder A, Fulda C, Nakagawa H, Rustgi AK, Blum HE, Opitz OG. Creating oral squamous cancer cells: A cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci USA 2005; 102(43):15599-604.
71. Kaelin Jr WG. Functions of the retinoblastoma protein. Bioessays 1999; 21:950-8.
72. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002; 7:d641-9.
73. Drayton S, Brookes S, Rowe J, Peters G. The significance of p16INK4a in cell defences against transformation. Cell Cycle 2004; 5:611-15.
74. Voorhoeve M, Agami R. Unraveling human tumor suppressor pathways: A tale of the INK4A locus. Cell Cycle 2004; 5:616-20.
75. Sellers WR, Kaelin Jr WG. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 1997; 15:3301-12.
76. Shen Y, White E. p53-dependent apoptosis pathways. Adv Cancer Res 2001; 82:55-84.
77. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
78. Jacks T, Weinberg RA. Cell-cycle control and its watchman. Nature 1996; 381:643-4.
79. Harris CC. p53 tumor suppressor gene: From the basic research laboratory to the clinic- an abridged historical perspective. Carcinogenesis 1996; 17:1187-98.
80. Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. Cancer Res 2001; 61:7642-6.
81. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001; 2:731-7.
82. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB, Popescu NC, Weinberg RA. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 2002; 99:12606-11.
83. Chang S, DePinho RA. Telomerase extracurricular activities. Proc Natl Acad Sci USA 2002; 99:12520-2.
84. Rundell K, Parakati, R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 2001; 11:5-13.
85. Skoczylas C, Fahrbach K, Rundell K. Cellular targets of the SV40 small-t antigen in human cell transformation. Cell Cycle 2004; 5:606-10.
86. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: Interaction with host proteins. Semin Cancer Biol 2001; 11:15-23.
87. Ruediger R, Pham HT, Walter G. Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene. Oncogene 2001; 20:1892-9.
88. Ruediger R, Pham HT, Walter G. Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene. Oncogene 2001; 20:10-5.
89. Sullivan CS, Pipas JM. T antigens of simian virus 40: Molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 2002; 66:179-202.
90. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 2004; 5:127-36.
91. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 2003; 3:483-95.
92. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6:308-18.